Astrana Health, Inc. (ASTH)
USD 35.04
(-1.35%)
USD 35.04
(-1.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 27.2 Million USD | 146.38% |
| 2022 | -58.66 Million USD | -82.67% |
| 2021 | -32.11 Million USD | -147.87% |
| 2020 | 67.08 Million USD | -56.24% |
| 2019 | 153.28 Million USD | 264.42% |
| 2018 | -93.23 Million USD | 17.87% |
| 2017 | -113.51 Million USD | 0.0% |
| 2015 | -9.08 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 98.77 Million USD | 263.05% |
| 2024 Q2 | 150.14 Million USD | 52.0% |
| 2023 FY | 27.2 Million USD | 146.38% |
| 2023 Q3 | -38.35 Million USD | 39.7% |
| 2023 Q4 | 27.2 Million USD | 170.94% |
| 2023 Q2 | -63.6 Million USD | -38.47% |
| 2023 Q1 | -45.93 Million USD | 21.7% |
| 2022 Q2 | -11.01 Million USD | 69.78% |
| 2022 FY | -58.66 Million USD | -82.67% |
| 2022 Q4 | -58.66 Million USD | -250.08% |
| 2022 Q3 | 39.08 Million USD | 454.95% |
| 2022 Q1 | -36.44 Million USD | -13.47% |
| 2021 Q2 | 23.32 Million USD | 0.0% |
| 2021 FY | -32.11 Million USD | -147.87% |
| 2021 Q3 | -4.9 Million USD | -121.02% |
| 2021 Q4 | -32.11 Million USD | -554.99% |
| 2020 FY | 67.08 Million USD | -56.24% |
| 2019 FY | 153.28 Million USD | 264.42% |
| 2018 FY | -93.23 Million USD | 17.87% |
| 2017 FY | -113.51 Million USD | 0.0% |
| 2015 FY | -9.08 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 98.071% |
| Addus HomeCare Corporation | 110.39 Million USD | 75.354% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 69.569% |
| Amedisys, Inc. | 341.35 Million USD | 92.03% |
| American Oncology Network, Inc. | 99.78 Million USD | 72.735% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 98.13% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 12382.46% |
| biote Corp. | 25.86 Million USD | -5.172% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -159.362% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 330.041% |
| COMPASS Pathways plc | -187.58 Million USD | 114.504% |
| DocGo Inc. | -12.78 Million USD | 312.737% |
| The Ensign Group, Inc. | 1.36 Billion USD | 98.002% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 354.39% |
| InnovAge Holding Corp. | 56.08 Million USD | 51.493% |
| Assure Holdings Corp. | 14.68 Million USD | -85.309% |
| The Joint Corp. | -2.47 Million USD | 1197.295% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 93.705% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 549.661% |
| ModivCare Inc. | 1.13 Billion USD | 97.608% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -9670.91% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -570.896% |
| Option Care Health, Inc. | 822.56 Million USD | 96.692% |
| P3 Health Partners Inc. | 83.7 Million USD | 67.497% |
| P3 Health Partners Inc. | 83.7 Million USD | 67.497% |
| The Pennant Group, Inc. | 323.57 Million USD | 91.592% |
| Surgery Partners, Inc. | 2.86 Billion USD | 99.051% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 997.337% |
| Talkspace, Inc. | -123.9 Million USD | 121.957% |
| Talkspace, Inc. | -123.9 Million USD | 121.957% |
| The Oncology Institute, Inc. | 86.32 Million USD | 68.484% |
| The Oncology Institute, Inc. | 86.32 Million USD | 68.484% |